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Abstract
Inhibitors of kappa B (IkBs) -a,- b and -e effect selective regulation of specific nuclear factor of kappa B (NF-kB) dimers
according to cell lineage, differentiation state or stimulus, in a manner that is not yet precisely defined. Lymphocyte antigen
receptor ligation leads to degradation of all three IkBs but activation only of subsets of NF-kB-dependent genes, including
those regulated by c-Rel, such as anti-apoptotic CD40 and BAFF-R on B cells, and interleukin-2 (IL-2) in T cells. We report that
pre-culture of a mouse T cell line with tumour necrosis factor-a (TNF) inhibits IL-2 gene expression at the level of
transcription through suppressive effects on NF-kB, AP-1 and NFAT transcription factor expression and function. Selective
upregulation of IkBe and suppressed nuclear translocation of c-Rel were very marked in TNF-treated, compared to control
cells, whether activated via T cell receptor (TCR) pathway or TNF receptor. IkBe associated with newly synthesised c-Rel in
activated cells and, in contrast to IkBa and -b, showed enhanced association with p65/c-Rel in TNF-treated cells relative to
controls. Studies in IkBe-deficient mice revealed that basal nuclear expression and nuclear translocation of c-Rel at early
time-points of receptor ligation were higher in IkBe2/2 T and B cells, compared to wild-type. IkBe2/2 mice exhibited
increased lymph node cellularity and enhanced basal thymidine incorporation by lymphoid cells ex vivo.I kBe2/2 T cell
blasts were primed for IL-2 expression, relative to wild-type. IkBe2/2 splenic B cells showed enhanced survival ex vivo,
compared to wild-type, and survival correlated with basal expression of CD40 and induced expression of CD40 and BAFF-R.
Enhanced basal nuclear translocation of c-Rel, and upregulation of BAFF-R and CD40 occurred despite increased IkBa
expression in IkBe2/2 B cells. The data imply that regulation of these c-Rel-dependent lymphoid responses is a non-
redundant function of IkBe.
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Introduction
Members of the nuclear factor of kappa B (NF-kB) transcription
factor family, p50, p52, p65 (RelA), c-Rel and RelB, are
maintained as inactive homo- or heterodimers in the cytoplasm
by inhibitors of kappa B (IkBs). Interactions are via ankyrin
repeats of IkB and Rel homology domains (RHD) of NF-kB [1,2].
The RHDs contain dimerisation, nuclear localisation and DNA-
binding regions, and c-Rel, p65 and RelB, but not p50 and p52,
also have transactivation domains which confer transcriptional
activity. c-Rel, p65 and p50 are regulated by IkBs -a,- b and -e
whose phosphorylation, ubiquitination and degradation are
effected following activation of the IkB kinase (IKK) complex,
particularly IKK2, when the classical NF-kB pathway is activated
[3]. c-Rel, p65 and p50 also associate with the intramolecular IkB
domains of p105 and p100, precursor proteins of p50 and p52
respectively. p50 is generated through constitutive processing, and
p52 upon activation of the alternative, IKK1-dependent pathway,
which also involves RelB. IkB degradation permits nuclear
translocation of NF-kB and induction of genes responsible for
many cellular responses including inflammation, survival and
differentiation [4,5,6].
Activated NF-kB itself induces resynthesis of all three IkBs.
How, then, are signal-, cell- and subunit-specific regulation of NF-
kB dimers and their target genes brought about? Studies suggest
that the necessary specificity may be achieved via differential
expression - in space and time - of IkB isoforms. Thus, the rate of
degradation and resynthesis of each isoform may vary with
stimulus and cell-type [7], and according to the differentiation
status of a cell. IkBe, for example, is upregulated in HL60 cells as
they undergo terminal differentiation and IkBe is expressed at
high levels in both naı ¨ve murine splenic B cells and IgM+ mouse B
cell lines, relative to IgG+ cells [8,9]. IkBe differs from IkBs -a and
-b structurally [8]; and IkBs differ from one another in preferential
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bind p65/p50, but IkBs -e and -b prefer c-Rel and p65
[8,10,11,12,13,14]. Further, although IkBe associates with p50
and p52 in vivo and in vitro, it is DNA-binding of cRel/p50 and
cRel or p65 dimers which it inhibits [15], suggesting that IkBe
regulates genes transactivated by heterodimers of c-Rel and
homodimers of RelA. Functionally, IkBe and IkBa both
contribute to post-induction repression of transcription by
removing NF-kB from the nucleus, whereas newly-synthesised
IkBb forms a ternary complex with NF-kB on DNA to maintain
its transcriptional activity [16,17]. Recent studies suggest that
differential regulation of IkBe may also be effected through
interactions with the protein phosphatase 6 (PP6) ternary complex
[18,19,20].
c-Rel, the prototype member of the NF-kB family, is expressed
in lymphoid, myelomonocytic and erythroid cells in haematopoi-
etic organs of both adult and foetus, and is essential for normal
function of B and T cells, macrophages and dendritic cells. Its
expression and activation are regulated according to cell lineage,
developmental and differentiation state, as well as stimulus
received by the cell [21,22]. For example, c-Rel is constitutively
cytosolic in naı ¨ve B lymphocytes but nuclear in mature B cells, an
altered state attributed to an increased rate of degradation of IkBa
in mature B cells [23] but which perhaps better reflects the down-
regulation of IkBe in the latter [9]. As a second example, the
cytosolic pool of c-Rel in resting T lymphocytes is not translocated
instantly to the nucleus following stimulation via the T cell
receptor (TCR). Rather, newly synthesised c-Rel only appears in
the nucleus after 1.522 hours of TCR activation [24]. This study,
which predated the discovery of IkBe, suggested that differential
subunit- and cell-specific regulation of NF-kB was effected by
IkBa and -b. Thus, mechanisms of temporal and spatial regulation
by IkB of c-Rel have not been fully defined in lymphocytes.
c-Rel upregulates genes involved in survival, proliferation or
differentiation including c-Rel itself, interleukin- 2 (IL-2) in T cells,
and genes involved in B cell survival [22,25,26]. AP-1 and NFAT
transcription factors are also required for full activation of the IL-2
proximal promoter (pIL-2), but c-Rel is essential for IL-2
expression [27,28,29,30]. c-Rel is required for induction of
CD40. CD40 was originally detected on B lymphocytes but has
since been shown to be expressed on T cells and antigen
presenting cells such as dendritic cells, as well as non-haemato-
poietic endothelial cells and fibroblasts [26,31,32,33]. Ligation of
CD40 on B cells delivers anti-apoptotic, maturation and
proliferative signals to the B cell [34]. Prolonged activation of c-
Rel, such as occurs during B cell maturation, also promotes B cell
receptor-dependent induction of B cell activating factor receptor
(BAFF-R) and its downstream target p100/NF-kB2, rendering B
cells competent for the anti-apoptotic BAFF signal [35,36].
Furthermore, both CD40 and BAFF-R have been reported to
interact and cooperate with nuclear c-Rel, but not p65, to
upregulate their own ligands on B cells [37,38].
An earlier focus of our laboratory has been the study of the
effects of tumour necrosis factor-a (TNF), whose expression is
dysregulated in inflammatory diseases such as rheumatoid
arthritis, on T cell function [39,40]. Specifically, we wanted to
elucidate mechanisms whereby TNF caused profound, reversible
inhibition of subsequent IL-2 induction in mouse T cell
hybridomas [41,42]. In the work presented here, we show that
induction of IL-2 was suppressed at the level of transcription and
that TNF inhibited PMA and ionomycin-induced expression,
nuclear translocation and transcriptional activity of AP-1, NFAT
and NF-kB to a greater or lesser extent. TNF pre-treatment also
inhibited NF-kB signalling when cells were subsequently restim-
ulated with TNF. Thus prolonged culture in TNF affected 11A2 T
cell signalling in a number of ways, many of which were likely to
contribute to the profound suppression of IL-2 production
In the course of these studies, however, we became most
interested in the two clearest and most consistent effects of TNF,
which were a very marked inhibition of nuclear translocation of c-
Rel, compared to p65, AP-1 or NFAT and, secondly, selective
upregulation and impaired degradation of IkBe, out of the IkBs.
We wondered to what extent the first phenomenon was a
consequence of the second and wanted to explore whether this
was an example of selective regulation of c-Rel by IkBe in
lymphocytes. Our hypothesis was that, in the absence of IkBe,c -
Rel would appear in the nucleus of unstimulated and naı ¨ve
lymphocytes and the cells would therefore show altered expression
of c-Rel-dependent genes. We found increased nuclear expression
of c-Rel in unstimulated T cell blasts and in naı ¨ve splenic B cells
from IkBe-deficient mice, despite increased basal expression of
IkBa in these mice. IkBe deficiency was associated with increased
lymph node cellularity and basal thymidine incorporation of
lymphoid cells ex vivo. We observed increased lymph node B cell
numbers in vivo and enhanced B lymphocyte survival ex vivo which
was associated with upregulation of CD40 and BAFF-R in
IkBe2/2 mice. The data suggest that negative regulation of these
c-Rel-dependent pro-survival genes is a non-redundant function of
IkBe in B cells. We propose that modulation of IkBe expression
and degradation is an important mechanism whereby the fine-
tuning of appropriate c-Rel activity is achieved in lymphoid cells.
Materials and Methods
Antibodies and reagents
Agonistic anti-CD3e mAb 145-2C11, and rat anti-mouse IL-2
antibody pairs were from BD-Biosciences, Oxford, UK. Antibod-
ies against c-Fos, Fos B, Fra-1, Fra-2, c-Jun, Jun B, Jun D, NFAT2
(NFATc1, clone 7A2), p65/RelA, c-Rel, p50 (NLS), and IkBs -a,
-b and -e, used for immunoblots, EMSA supershift and
immunoprecipitation, were all from Santa Cruz Biotechnology
(Insight Biotechnology, Wembley, UK). Agarose-conjugated anti-
c-Rel and anti-p65 Abs for immunoprecipitation were also from
Santa Cruz. Anti-NFAT1 (NFATp, NFATc2) antibody was from
Affinity Bioreagents
TM (Thermo Fisher Scientific, Loughborough,
UK). HRP-linked antibodies for immunoblot were all from
DAKO (DAKO UK, Ely, UK). All flow cytometry antibodies
were from eBioscience (eBioscience Ltd, Hatfield, UK). EMSA
oligonucleotide probes: AP-1 59-CGCTTGATGAGTCAGCCG-
GAA-39; NF-kB5 9-AGTTGAGGGGACTTTCCCAGG-39 were
both from Promega (Promega UK, Southampton, UK); CD28RR
59-TTTAAAGAAATTCCAAAGAGTCATCA-39 (forward and
reverse primers from MWG (Eurofins MWG Operon, Ebersberg,
Germany); NFAT/AP-1 59-CGCCCAAAGAGGAAAATTTG-
TTTCATA-39 (Santa-Cruz/Insight Biotechnology, Wembley,
UK). Other reagents were from Sigma-Aldrich Company Ltd
(Dorset, UK) or BDH (VWR International, Lutterworth, UK).
Cells and Cell Culture
The derivation and culture of mouse T cell hybridoma clone
11A2, which is specific for human cartilage glycoprotein-39
(HCgp-39), restricted by HLA-DR4, and expresses human CD4,
has been described [43]. 11A2 cells were cultured in RPMI 1640
supplemented with 25 mM HEPES, 2 mM L-glutamine, 10%
heat-inactivated foetal calf serum, 100 U/ml penicillin, 100 mg/ml
streptomycin, 1 mM sodium pyruvate and 50 mM 2-mercapto-
ethanol, at 37uC and 5% CO2. Cells were passaged every
48 hours into fresh complete medium, in the presence or absence
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cell line A20 and B cell hybridoma SP2/0 were cultured in RPMI
containing 10% heat-inactivated foetal calf serum, 100 U/ml
penicillin, 100 mg/ml streptomycin and 50 mM 2-mercaptoetha-
nol, in the presence or absence of mTNF 20 ng/ml for 8 days at
37uC and 5% CO2.
Cell Stimulation and IL-2 assay
11A2 cells were harvested, washed and resuspended in complete
medium at 10
6 cells/ml in the absence of TNF, prior to
incubation with either plate-bound anti-CD3e, or with PMA
and ionomycin (Calbiochem, Merck Biosciences, Beeston, UK) at
the concentrations and for the times indicated. IL-2 protein in cell
supernatants was assayed by fluorescent immunosorbant assay, as
described [41].
Ribonuclease protection assay and RNA stability
Control and TNF-treated 11A2 cells were resuspended in
complete medium at 10
6 cells/ml in the absence of TNF, then
incubated with either plate-bound anti-CD3e 10 mg/ml, or PMA
and ionomycin for the times indicated. Cells were harvested,
washed in ice-cold PBS and total RNA extracted (QIAampH RNA
Blood Mini Kit, Qiagen, Crawley, UK). mRNA species were
visualised by ribonuclease protection assay (BD RiboQuant
TM kit
mCK-1, BD Biosciences) and phosphor-imaging (Fuji FLA 2000).
For stability studies, actinomycin D 10 mg/ml was added after
4 hours’ stimulation, and cells were harvested at the times
indicated, washed in ice-cold PBS and snap-frozen until RNA
was extracted and analysed.
Transfections and reporter assays
Control and TNF-treated 11A2 T cells (5610
6210
7 cells per
point) were transfected using AmaxaH NucleofectorH I, Kit VH,
programme A10 (AmaxaH, Lonza Wokingham, Ltd, UK) with
10 mg firefly luciferase reporter vectors pAP-1-TA-luc (TRE
consensus sequence), pNFAT-TA-luc (ARRE-2 from mouse pIL-
2), or pNF-kB-TA-luc (consensus response element of mouse
MHCII invariant chain) (all from Takara Bio Europe/Clontech,
Lonza Wokingham, Ltd, UK). In all cases, cells were co-
transfected with 0.2 mg phRL-SV40 expressing Renilla luciferase
(Promega UK), to normalise data for transfection efficiency. Note:
Among many other transcription factor binding sites, the SV40
promoter/enhancer of phRL-SV40 contains two NF-kB consen-
sus sequences with the potential for interference in NF-kB-
dependent promoter assays. However, transfecting with the lowest
feasible amount of phRL-SV40 DNA, we found the stimulation
index (due to PMA and ionomycin) of renilla luciferase expression
was similar for control and TNF-treated cells in all experiments.
Thus any differences seen between control and TNF-treated cells
in terms of firefly luciferase normalised to renilla luciferase
expression were independent of effects of TNF pre-treatment on
phRL-SV40. Transfected cells were plated out at 10
6/ml, allowed
to recover for two hours, then stimulated with PMA 50 ng/ml and
ionomycin 100 ng/ml for up to 6 hours. Cell lysates were assayed
for luminescence due to firefly and renilla luciferase activities
(Dual-Luciferase Reporter
TM assay, Promega UK).
Generation of pFLAG-CMV4-c-Rel
The murine c-Rel sequence was digested from cloning vector
pSPORT (Invitrogen, Paisley, UK), end-filled to allow cloning into
expression vector pFLAG-CMV4 (Sigma-Aldrich) and repaired for
a ‘stop’ codon mutation at the end of the rel homology domain
before sequencing across pFLAG-c-Rel (Eurofins MWG Operon,
London, UK). Expression of c-Rel and HA immunoreactivity of the
correct size was confirmed by immunoblot following lipofection of
NIH-3T3 fibroblasts. For reconstitution experiments in 11A2 cells,
2 mg of pFLAG-CMV4-c-Rel or empty vector were used.
EMSAs, immunoblots, and immunoprecipitations
Control and TNF-treated cells (10
6/ml) were stimulated with
PMA 10 and ionomycin 50 ng/ml, or PMA 50 and ionomycin
100 ng/mlforthetimesindicated.Cells were harvested andwashed
in ice-cold PBS. Cytoplasmic and nuclear extracts wereprepared by
a method adapted from Dean et al [44]: 5610
6 cells were
resuspended in 500 ml hypotonic lysis buffer (10 mM HEPES
pH 7.6, 40 mM KCl, 3 mM MgCl2, 5% glycerol, 1% Triton X-
100, 2 mM DTT, 2 mM NaF, 1 mM Na3VO4,2 5 m Mb-
glycerophosphate and protease inhibitor cocktail 10 ml/ml) for 5
minutes on ice. After centrifugation at 500 g x 3 minutes at 4 uC, the
supernatant was saved (cytosolic fraction), and pelleted nuclei
washed in 250 ml wash buffer (10 mM HEPES pH 7.6, 10 mM
KCl, 1.5 mM MgCl2, 1 mM DTT, 2 mM NaF, 1 mM Na3VO4,
25 mM b-glycerophosphate and protease inhibitor cocktail 10 ml/
ml). A sample was examined for successful nuclear extraction of
intact nuclei by light microscopy. Nuclei were pelleted as before
then extracted in 150 ml nuclear extraction buffer (20 mM HEPES
pH 7.6, 420 mM NaCl, 1.5 mM MgCl2, 25% glycerol, 1 mM
DTT, 0.2 mM EDTA, 2 mM NaF, 1 mM Na3VO4,2 5m Mb-
glycerophosphate and protease inhibitor cocktail 10 ml/ml) for 15
minutes on ice, subjected to one freeze-thaw cycle at 280 uC, and
clarified by centrifugation at 14,0006g for 15 minutes at 4 uC.
Nuclear extract and cytosol were stored at 280 uC until use. For
immunoblot, up to 20 mg nuclear or cytosolic proteins were
separated by SDS-PAGE (NuPAGE Bis-Tris MOPS system,
Invitrogen) and proteins of interest detected by immunoblot and
ECL (GE Healthcare Life Sciences, Amersham, UK). Immunoblots
of all nuclear and cytoplasmic proteins were probed for b-actin,
which is abundant in both nucleus and cytoplasm [45,46], and a-
tubulin, abundant in cytoplasm only. Actin detected in the absence
of tubulin indicated freedom of nuclear extracts from cytosolic
contamination and was used to normalise for protein loading in
both nuclear and cytosolic immunoblots. For EMSA, 5 mg nuclear
proteinswereincubatedwith
32P end-labelled oligonucleotideprobe
for 15 minutes at room temperature then separated in a 6% non-
denaturing polyacrylamide gel, the gel dried, and protein-bound
oligonucleotide detected by phosphor-imaging and by exposure of
photographic film to dried gel. For probe competition, cold probe
was added to the incubation in 100-fold excess. For super-shifting
assays,proteinswereincubatedwith1 mgantibodyfor10minutesat
room temperature prior to addition of radiolabelled probe. For
immunoprecipitations, 5610
6 cells were lysed in 500 ml5 0m M
TRIS.HCl pH 8, 200 mM NaCl, 1% TX-100, 1 mM DTT,
0.1 mM EDTA, 1 mM Na3VO4,5 0 m MN a F ,1 0 m Mb-
glycerophosphate, and protease inhibitor cocktail 10 ml/ml. IkB
and NF-kB proteins were immunoprecipitated from 100 mg
clarified lysate and analysed by immunoblot for the target and co-
immunoprecipitated proteins.
IkBe2/2 mice
The IkBe coding sequence was replaced by an nlslacZ/IRESneo
construct and fully back-crossed onto the C57BL/6J background
as reported previously by Me ´met and colleagues [47]. Mice were
bred and housed in a specific pathogen-free environment and
genotyped by PCR, as described (30). IkBe +/+ wild-type, +/2
heterozygote, or 2/2 homozygote knockout (.7 weeks or ,18
weeks old) male mice were used in all experiments unless otherwise
stated. Where WT mice were not littermates of IkBe2/2
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beside the mutant animals for at least 14 days prior to
experimentation. Mice were killed by cervical dislocation or
asphyxiation with CO2, and spleen and lymph nodes (subman-
dibular, axillary, inguinal, popliteal, mesenteric and para-aortic)
dissected, from which splenocytes and lymph node cells (LNC)
were prepared.
Generation of primary T cell blasts, T cell stimulation,
nuclear and cytoplasmic extracts and immunoblotting;
assay of intracellular IL-2
Mixed splenocytes and LNC were cultured at 8610
6 cells/ml in
complete medium containing anti-CD3e 100 ng/ml at 37 uC and
5% CO2. After 48 hours, cells were washed and resuspended to
the same cell density in fresh medium containing recombinant
murine IL-2, 20 units/ml. After a further 48 hours, fresh medium
and IL-2 were added, to the same final concentration. Three days
later, T cell blasts were washed and restimulated with plate-bound
anti-CD3e 5 mg/ml (5610
6 cells per sample) for up to 4 hours at
37 uC and 5% CO2, before harvesting on ice, by scraping, and
preparation of nuclear and cytosolic extracts as above (per 5610
6
cells: 150 ml hypotonic lysis buffer, 75 ml wash buffer, 40 ml
nuclear extraction buffer). 15 mg cytosolic proteins, or total nuclear
extracts were assayed for NF-kB and IkB proteins by immunoblot.
Relative expression of nuclear and cytosolic proteins was
calculated from quantitative densitometric scans (GS710 Calibrat-
ed Imaging Densitometer with Quantity One software [Bio-Rad
Laboratories, Hemel Hempstead, UK]) using the Phoretix 1D
software (Non-Linear Dynamics, Newcastle-upon-Tyne, UK). In
parallel experiments, cells (2.5610
5 cells per point) were
stimulated with PMA 10 ng/ml and ionomycin 500 ng/ml in
the presence of brefeldin A 10 mg/ml for 6 hours at 37 uC and 5%
CO2. Cells were then washed and labelled with anti-CD4-PE-Cy7
and anti-CD8-PE labelled antibodies, both at 1:100 in FACS
buffer (2% BSA, 0.02% sodium azide in PBS), for 20 minutes at 4
uC in the dark. Surface-labelled cells were washed and fixed in
paraformaldehyde (2%) for 10 minutes at room temperature,
washed, permeabilised with saponin 2% in FACS buffer, and
labelled with anti-IL-2-FITC 1:50 in permeabilisation buffer for
1 hour at 4uC in the dark. Labelled cells were washed and flow
cytometry data acquired in a BD
TM LSR II flow cytometer prior
to analysis using FACSDiva
TM software (BD Biosciences).
Thymidine incorporation assay
Splenocytes or LNC were plated at 5610
4 cells per well in 200 ml
complete medium and stimulated for 48 hours with soluble anti-CD3e
and anti-CD28 at a range of concentrations at 37 uCa n d5 %C O 2.
100 ml conditioned medium was then removed from each well, for
cytokine analysis, and 1 mCi
3H-thymidine added. After 18 hours’
further incubation,
3H-thymidine incorporation was measured in a
MicroBeta JET plate-reader (Perkin Elmer, Buckinghamshire, UK).
Lymphocyte phenotyping and B cell selection and
survival
Splenocytes, LNC, or B and T cell numbers and viability were
assayed by trypan blue exclusion under light microscopy or by flow
cytometry (FSc/SSc live gate). Cell phenotypes were analysed by
flow cytometry after labelling with anti-B220-FITC, anti-CD11b-
APC and anti-CD4/CD8 antibodies as above. B cells were
prepared from spleens by positive selection using anti-CD19-coated
magnetic beads according to the manufacturer’s instructions
(Miltenyi Biotech Ltd, Bisley, UK). B cells - more than 90% pure
by B220-FITC labelling - were cultured without antigen receptor
stimulation at 10
6 cells per well (per ml) in 24 well plates for
48 hours at37 uCand5%CO2 andassayeddailybyflowcytometry
for viability and receptor expression using either anti-B220-FITC
plus anti-CD40-APC, or anti-BAFF-R-FITC plus anti-CD40-APC.
In other experiments, purified B cells were cultured as above but in
the presence of 10 mg/ml anti-IgM F(ab’)2 fragment (Jackson
ImmunoResearch Europe, Ltd, Newmarket, UK ) plus 2 units/ml
mIL-4 (R&D Systems, Oxford, UK) for up to 72 hours and assayed
daily by flow cytometry for viability and receptor expression using
anti-B220-FITC plus anti-CD40-PE and anti-BAFF-R-APC.
B cell stimulation, nuclear and cytoplasmic extracts and
immunoblotting
Splenic B cells were prepared as above from 3 age- and sex-
matched WT and IkBe2/2 mice plated at 10
7 cells per ml in a
12-well plate in complete medium at 37 uC and 5% CO2, and
allowed to recover for 2 hours. Cells were then stimulated (10
7 per
condition) for 0, 0.5 and 1 hour with 10 mg/ml anti-IgM F(ab’)2
fragment, and nuclear and cytoplasmic extracts prepared as for T
cells. Total nuclear extracts or 10 mg cytosolic proteins were
immunoblotted for c-Rel, p65, NFAT2, c-Fos, IkBe and -a and
actin. Detection was by chemiluminescence in a BioRad Chemi
Doc
TM XRS+ Molecular ImagerH and c-Rel expression relative to
actin expression analysed with Image Lab
TM software.
Results
TNF inhibits IL-2 gene transcription and attenuates
induction of AP-1 and NFAT
When studying effects of TNF on T cell function, we observed
that pre-treatment of mouse T cell hybridoma 11A2 with picomolar
concentrations of TNF suppressed induction of secreted IL-2
protein by more than 90%, relative to untreated cells. Major
suppression occurred whether T cells were activated via TCR or
with two non-toxic concentrations of PMA and ionomycin, being
partly recovered when the higher of the two was used (P+I)high,a n d
was therefore independent of any attenuation of TCR-proximal
signalling that we have reported previously (Figure 1A and [41,42]).
Inhibition of IL-2 inductionwasat thelevel ofmRNA expression,as
determined by ribonuclease protection assay, peak expression of IL-
2 mRNA being reduced by at least 90% in TNF-treated as
compared to control cells, for all stimuli (Figure 1B). We tested the
effect of TNF on stability of induced IL-2 mRNA and found that,
for cells stimulated with PMA plus ionomycin, IL-2 mRNA was
stable for up to 3 hours after addition of actinomycin D, even
though its peak expression in TNF-treated cells was ,10% that of
control cells (Figure S1, shown for (P+I)low ). This indicated that
inhibition of IL-2 induction in TNF-treated cells was not due to
reduced mRNA stability. Therefore, we focussed our studies on the
effects of TNF on transcriptional regulation of IL-2.
The IL-2 proximal promoter (pIL-2) contains simple and
composite binding sites for NFAT, AP-1 (Fos/Jun) and NF-kB
transcription factors. We compared induction and nuclear
translocation of AP-1, NFAT and NF-kB proteins in control and
TNF pre-treated cells by immunoblotting. AP-1 exists as
homodimers of jun (c-Jun, Jun B, Jun D) or heterodimers of Fos
(c-Fos, Fos B, Fra-1 and Fra-2) and Jun. Induction of nuclear c-Fos
by PMA and ionomycin was rapid and transient in control 11A2
cells, being detectable at 30 minutes, peaking at 2 hours and
diminishing at 4 hours. In TNF-treated cells, by contrast, its
induction was delayed and more transient (Figure 1C, panel 1).
Nuclear Fos B was also attenuated in TNF-treated cells as was, to a
lesser extent, c-Jun (panels 2 and 3). However, inducible nuclear
Jun B was unaffected by TNF (panel 4). Fra-1 and Fra-2 were not
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hyper-phosphorylated NFAT is bound to inactive calcineurin
phosphatase in the cytoplasm. A sustained calcium signal activates
calcineurin, leading to dephosphorylation and nuclear transloca-
tion of NFAT. NFAT1 is constitutively expressed in T cells
whereas NFAT2 is inducible. In 11A2 cells, dephosphorylated
NFAT1 was expressed constitutively in the nucleus, to similar
levels in control and TNF-treated cells (Figure S2). Induced
nuclear NFAT2 was detected at two hours, with levels increasing
after 4 hours’ stimulation (Figure 1D). Its nuclear expression was
lower and slightly delayed relative to control cells, but NFAT2 was
nonetheless strongly induced, dephosphorylated and imported to
the nucleus in TNF-treated cells.
TNF pre-treatment inhibits subsequent induction and
nuclear expression of NF-kB associated with
upregulation of IkBe
p65 and c-Rel were detected in the cytosols of resting control
and TNF-treated 11A2 cells (Figure 2A, panels 1, 3). Newly-
synthesised c-Rel appeared in the cytosol of control and, to a lesser
extent, TNF-treated cells after 1–2 hours’ stimulation with PMA
and ionomycin (Figure 2A, panel 1). However, nuclear c-Rel,
detectable at 2 hours, was greatly reduced in TNF-treated relative
to control cell samples (panel 2) and remained barely detectable at
6 or 8 hours (not shown). TNF-treated cells also showed a
reduction in nuclear translocation of both p65 (panel 4) and p50,
more p50 being retained in the cytosol of TNF-treated compared
to control cells (panels 5, 6).
To test whether the inhibitory effects of TNF on NF-kB signalling
were limited to the TCR pathway, whose activation is mimicked by
PMA and ionomycin, we analysed nuclear and cytosolic NF-kBi n
control and TNF-pre-treated 11A2 cells following acute restimulation
with TNF (50 ng/ml). Acute TNF stimulation led to rapid, transient
nuclear translocation of c-Rel,p65 and p50 which peaked between30
minutes and 1 hour of stimulation (Figure 2B, panels 2, 4, 6).
However,c-RelwasbarelydetectableinnuclearextractsofTNF-pre-
treated cells at any time-point of acute TNF stimulation (panel 2). By
contrast, acute TNF-induced nuclear translocation of p65 and p50
was only slightly reduced at most time-points tested (panels 4, 6),
although more p50 remained in the cytosol of TNF-pre-treated cells
Figure 1. TNF inhibits IL-2 gene transcription and attenuates induction of AP-1 and NFAT. 11A2 cells were cultured with or without TNF
2.5 ng/ml for 8 days before (A) restimulation with plate-bound anti-CD3e 5 mg/ml, PMA 10 ng/ml and ionomycin 50 ng/ml (P+I)low, or PMA 50 ng/ml
and ionomycin 100 ng/ml (P+I)high for 24 hours. Secreted IL-2 protein was measured by immunoassay (mean +/2 SEM, n=5 experiments); (B)
restimulation as above for 4 hours followed by RNA extraction, and analysis for IL-2 mRNA by RNase protection assay (mean +/2 SD, n=3
experiments). After restimulation with (P+I)low, nuclear and cytoplasmic extracts were prepared, and equivalent amounts of protein assayed by
immunoblot for (C) nuclear AP-1 and (D) nuclear NFAT2 (representative of 3 experiments for each condition). Each blot was probed then reprobed for
the indicated proteins.
doi:10.1371/journal.pone.0024504.g001
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treatment of 11A2 cellswith TNF also inhibited TNF-R-induced NF-
kB nuclear translocation, most markedly that of c-Rel. These data
suggested that the effects of TNF pre-treatment on NF-kB activation
were not restricted to TCR/CD28-dependent pathways involved in
IL-2 gene expression. Rather, TNF attenuated NF-kB activity by
modulating a receptor-distal factor common to TCR- and TNF-R-
dependent NF-kB activation, IkB being a good candidate.
We therefore examined inducible degradation of IkBs -a,- b
and -e by PMA and ionomycin (Figure 2C) or TNF re-stimulation
(Figure 2D), in control and TNF-treated cells. TNF pre-treatment
led to increased basal levels of IkBe, but not of -a or -b (Figure 2C,
D: compare first and second lanes). IkBs -a and -b were rapidly
degraded to similar degrees in control and TNF-treated cells in
response to either stimulus (Figure 2C, D; panels 1 and 2) and
were re-expressed after 1–2 hours (a), or 2–4 hours (b), of
stimulation, re-expression of IkBb being more marked in control
than TNF-treated cells. By contrast, IkBe was present at increased
levels in TNF-treated compared to control cells for stimulations of
up to 2 hours. IkBe also appeared resistant to PMA and
ionomycin-induced degradation (compare 0.5 and 1 hour time-
points of control and TNF-treated cells, Figure 2C, D, panels 3),
and returned to unstimulated cell levels more rapidly in TNF pre-
treated than in control cells (compare 0 and 1 hour time-points of
control and TNF-treated cells, Figure 2C, D; panels 3). Thus, both
inhibition of nuclear translocation of NF-kB, particularly of c-Rel,
and sustained, increased expression of IkBe in TNF pre-treated
cells were evident upon acute activation TCR and TNF-R
pathways.
Transcription factor DNA binding and activity are
suppressed by TNF: transcriptional activity partially
restored by exogenous c-Rel
We used electrophoretic mobility shift assay (EMSA) to test
whether reduced nuclear levels of NF-kB, AP-1 and NFAT proteins
in TNF-treated 11A2 cells were reflected by attenuated DNA-
binding. Inducible binding to radiolabelled NF-kB consensus
Figure 2. TNF pre-treatment inhibits subsequent induction and nuclear expression of NF-kB and upregulates IkBe. 11A2 cells were
cultured with or without TNF 2.5 ng/ml for 8 days before restimulation with PMA 10 ng/ml and ionomycin 50 ng/ml or TNF 50 ng/ml for the time-
points indicated. Nuclear and cytoplasmic extracts were prepared and equivalent amounts of protein assayed for the presence of NF-kB transcription
factors (A, B) and IkB isoforms (C, D) by immunoblot. Each blot represents at least three similar experiments, probed then reprobed for the indicated
proteins.
doi:10.1371/journal.pone.0024504.g002
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4 hours’ stimulation with PMA and ionomycin in control cell
extracts (Figure 3A, lanes 7 and 9). Two inducible protein/DNA
complexes (upper complex I, lower complex II) were observed. At
these time points, which correspond to those for induction and
nuclear translocation of c-Rel by PMA and ionomycin, the intensity
ofsignal duetobothcomplexes,particularlycomplex I,was lowerin
TNF-treated relative to control cell samples (Figure 3A, compare
lanes 7 and 8, and 9 and 10). Analysis of NF-kB in complexes I and
II following 4 hours’ stimulation of cells, using subunit-specific
Figure 3. Transcription factor DNA binding and activity are suppressed by TNF. Activation of pCD28RR partially restored by exogenous c-
Rel. Control and TNF-treated 11A2 T cells were activated with (P+I)high. Nuclear extracts were incubated with (A)
32P-labelled NF-kB consensus
oligonucleotide or cold competitor probe or (B)
32P-labelled NF-kB oligonucleotide with or without NF-kB supershifting antibodies, before non-
denaturing gel electrophoresis. Protein-bound oligonucleotide was visualised by both phosphorimaging and exposure of the dried gel to
photographic film. Images are representative of three experiments. Control and TNF-treated cells were transfected with reporter plasmids (10 mg)
expressing firefly luciferase under control of (C) pAP-1, (D) pNFAT/AP-1, (E) pNF-kBconsensus, (F) pCD28RR(NF-kB/AP-1) promoters, and stimulated as
above for 6 hours. Firefly luciferase expression relative to pSV40-driven renilla luciferase from a co-transfected plasmid (0.2 mg) is shown (mean +/2
SEM for 9, 7, 4 and 5 experiments, respectively). (G) Summary of inducible promoter activities in TNF-treated cells as a percentage of induction in
control cells, for all experiments. (H) Control and TNF-treated 11A2 cells were cotransfected with 2 mg of empty vector or c-Rel expression plasmid
and pCD28RR reporter plus renilla luciferase plasmids prior to stimulation as for F. The dotted line represents stimulated expression in cells
transfected with empty vector (mean +/2 SEM, n=4 experiments).
doi:10.1371/journal.pone.0024504.g003
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protein (Figure 3B, lanes 9 and 10), and complex I, p65, c-Rel and
p50 (lanes 5–10). Markedly less c-Rel, p65 and p50 were detected in
inducible complexes I and II derived from TNF-treated, as
compared to control cell samples (compare lanes 4, 6, 8 and 10
with lanes 3, 5, 7 and 9). This difference in DNA-bound NF-kBw a s
greatest for complex I, consistent with the more marked TNF-
dependent reduction in nuclear c-Rel and p65 relative to p50
already observed.
Maximal inducible AP-1 protein binding to radiolabelled probe
was also greater in control compared to TNF-treated cell nuclear
extracts. Subunit-specific supershift indicated modest reductions in
DNA bound c-Fos and Jun B in TNF-treated cell extracts
compared to controls, but little or no difference in the amounts of
Fos B, Fra-2, c-Jun, or Jun D (Figure S3B, C; c-Jun not shown;
Fra-1 not detected). EMSA and supershift with anti-NFAT2
antibody revealed similar amounts of NFAT2 in inducible NFAT/
AP-1 binding complexes from control or TNF-treated cell
samples, despite reduced complex size for the latter (Figure
S3D). However, since reduced NFAT/AP-1 complex size in TNF-
treated cell samples was consistent in three experiments but the
supershift worked well only in the assay shown, the discrepancy
between antibody-supershifted and unshifted complex sizes may
be unique to this particular experiment. NFAT1 which was
constitutively nuclear in 11A2 cells and expressed to similar levels
in control and TNF-treated cells (Figure S2) was not assayed for
NFAT/AP-1 DNA binding.
In parallel experiments, we tested the effect of reduced nuclear
levels and attenuated DNA-binding of these transcription factors
on the ability of cells to activate promoters containing consensus
sequences for NF-kB, AP-1 and NFAT. The two composite
sequences in pIL-2 which have been shown to be important for
gene activation are an NFAT/AP-1 site at position 2274 to 2287
[27], and an NF-kB/AP-1 site also known as the CD28 response
region (CD28RR) at position 2147 to 2163 from the transcrip-
tion start site [28]; the non-consensus NF-kB-binding element in
CD28RR (CD28RE) preferentially binds c-Rel-containing dimers
in stimulated T cells [48]. We measured PMA and ionomycin-
stimulated expression of firefly luciferase under control of pAP-1,
pNFAT/AP-1, pNF-kB, or pCD28RR. Basal and induced firefly
luciferase activities were expressed relative to co-transfected
constitutive Renilla luciferase expression in the same cell lysate
sample (see Methods).
Transcriptional activation was suppressed in TNF-treated cells
as compared to control cells, for all promoters tested (Figure 3C–
3F), by 55–60% for pAP-1 and pNFAT/AP-1, 80% for pNF-kB
and 75% for pCD28RR (Figure 3G). These data correlate with the
greater attenuation which we observed in nuclear expression and
DNA-binding of NF-kB, particularly c-Rel, relative to NFAT and
AP-1, in TNF-treated cells. We therefore tested the ability of
exogenous c-Rel to overcome suppressed activation of pCD28RR
in TNF-treated T cells by co-transfecting c-Rel expression vector,
or empty vector, with firefly luciferase reporter and constitutive
Renilla luciferase plasmids. Co-transfection of TNF-treated 11A2
cells with c-Rel restored inducible activation of pCD28RR to a
level equivalent to that of control cells transfected with empty
vector (Figure 3H). However, exogenous c-Rel led to a 4-fold
increase in inducible pCD28RR activation for control as well as
TNF-treated cells, implying firstly that c-Rel concentration is
limiting in terms of activation of CD28RR in untreated 11A2 cells
and, secondly, that reconstitution of factors other than c-Rel –
such as AP-1 subunits – is required for maximal activation of
CD28RR in TNF-treated cells.
PMA and ionomycin-induced c-Rel associates with IkBa
and IkBe; persistent and enhanced association of IkBe
with p65/c-Rel in TNF-treated cells throughout
stimulation
Our data implied that TNF pre-treatment had inhibitory effects
on all three transcription factor families required for optimal
activation of the IL-2 promoter. However, we became most
interested in the selective increase in IkBe expression, out of the
IkBs, accompanied as it was by strong inhibition of c-Rel nuclear
translocation, out of all NF-kB subunits tested, in TNF-treated
cells. We decided to use this system to investigate the association of
c-Rel and IkBe further.
c-Rel has been shown to be chiefly associated with IkBb in
naı ¨ve, but with IkBa in TNF- and IL-1-stimulated, T cells [49].
However, the contribution of IkBe was not examined in that
study. Biochemical analysis demonstrated that IkBe binds c-Rel
and p65 hetero- or homodimers in preference to p65/p50, which
tends to be bound by IkBa [8]. We therefore explored the
composition of NF-kB/IkB complexes in TNF pre-treated cells
following stimulation with PMA and ionomycin. We immunopre-
cipitated IkBa,- b,o r- e from equal amounts (100 mg) of cytosolic
protein, and immunoblotted for associated NF-kB (Figure 4A; see
Figure S4A (i) and (ii) for proportions of each protein in cytosol
and post-IP supernatants). IkB proteins were precipitated
efficiently by their individual antibodies, since little IkB was
detected by immunoblot in post-IP supernatants (Figure S4A (i).
However, p65 and c-Rel were still detectable in these post-IP
supernatants (Figure S4B (ii)) suggesting that only a small
proportion of either NF-kB co-precipitated with a single IkB
isoform.
In resting cells c-Rel was associated with IkBb (Figure 4A, panel
4) and p65 was associated with both IkBa and b (Figure 4A, panels
2 and 5). A small amount of c-Rel and p65 also co-
immunoprecipitated with IkBe (Figure 4A, panels 7 and 8). The
amounts of p65 or c-Rel associated with each IkB were reduced
when the IkB was degraded, and increased as the IkB was
resynthesised, following stimulation. Newly synthesised c-Rel,
expressed after 2 hours, associated with IkBa and IkBe as well
as IkBb (Panels 1, 4 and 7, 2–4 hour time-points). The amounts of
p65 associating with IkBa and b, and the amount of c-Rel
associating with IkBb, were similar for control and TNF-treated
cell samples (Figure 4A, panels 2, 4 and 5). However, the amount
of c-Rel associated with IkBe was greater in TNF-treated cell
samples compared to controls up to 2 hours of stimulation (panels
7 and 9: 0–2 hour time-points). This difference was lost when IkBe
expression in control cells reached that of TNF-treated cells
(panels 7 and 9, 4 hour time-point). Thus the amount of c-Rel
immunoprecipitating with IkBe reflected the expression level of
IkBe. By contrast, association of newly-synthesised c-Rel with
IkBa reflected the greater abundance of c-Rel in control
compared to TNF-treated cells (Figure 4A, panels 1 and 3 and
Figure S4A (i) and (ii)). In three experiments, it was difficult to
obtain very clear bands for immunoprecipitated IkBs -b and -e,
because the signal for these 45 kD proteins ran just in front of the
heavy chain band of immunoprecipitating antibody in blots. We
were unable to detect p50 in any co-immunoprecipitation
experiment.
We also immunoprecipitated p65, using directly-conjugated
agarose beads, and blotted for associated IkB proteins. We were
unable to immunoprecipitate c-Rel directly by a similar method,
but found that a proportion of c-Rel co-precipitated with p65
(Figure 4B, panels 1 and 2). Blots of post-IP supernatants revealed
efficient co-immunoprecipitation of IkBs with p65 (Figure S4C).
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may be seen by variation in immunoprecipitated p65 signal
compared to the signal in input cytosol (Figure 4B, panel 1 and
Figure S4B, panel 1).
All three IkBs associated with p65/c-Rel complexes. In resting
and stimulated cells, the amounts of IkBs -a and -b associated with
p65/c-Rel were similar for control and TNF-treated cell samples,
once efficiency of the p65 pull-down was taken into account
(Figure 4B, panels 3 and 4 – compare with panel1). However, at all
time-points, more IkBe was associated with the p65/c-Rel
complexes in TNF-treated than in control cell extracts even when
expression of IkBe in control cells approached that of TNF-treated
cells, at four hours (Figure 4B, panel 5: lanes 9 and 10, compare
with Figure S4B panel 5). Taken together, these experiments
indicate that IkBe sequesters newly-synthesised c-Rel in propor-
tion to its own expression levels, and exhibits persistent, enhanced
association with p65/c-Rel complexes in TNF-treated cells.
To examine whether regulation of IkBe by TNF was a general
phenomenon, as opposed to a peculiarity of T cell hybridomas, we
cultured murine B cell lines, including A20 and hybridoma SP2/0,
as well as primary T cells of Balb/C and C57Bl/6J mice, in the
presence or absence of TNF. However, we failed to document
TNF-dependent upregulation of IkBe. Indeed, we observed very
high levels of IkBe in primary T cell blasts, regardless of the
presence of TNF. Therefore, in order to test our hypothesis – of
selective regulation of c-Rel by IkBe in primary cells – and explore
its functional consequences, we focussed our studies on lympho-
cytes from IkBe-deficient mice.
Increased basal nuclear c-Rel and reduced threshold for
TCR-dependent proliferation in IkBe null mouse T cells
We looked first at c-Rel nuclear expression in murine primary T
cell blasts, as a correlate of experiments in the 11A2 T cell line.
Splenocytes and lymph node cells (LNC) from age- and sex-
matched wild-type (+/+), heterozygote (+/2) or homozygous IkBe
null (2/2) mice were cultured for 48 hours in the presence of
anti-CD3 and expanded for 6 days in IL-2. T cell blasts were then
re-stimulated for up to 4 hours with plate-bound anti-CD3 and
analysed by immunoblot for NF-kB and IkB proteins. We
detected increased nuclear c-Rel in resting T cell blasts from
both IkBe+/2 and IkBe2/2 mice when compared to IkBe+/+,
and observed a negative correlation between IkBe gene dose and
nuclear c-Rel (Figure 5A and B, panels 1, 0 h time-points). This
difference in nuclear c-Rel was most marked for resting T cells and
decreased with time of TCR-restimulation until, by four hours’
TCR ligation, similar amounts of nuclear c-Rel were detected for
all genotypes (Figure 5A, panel 1). Relative band intensities due to
c-Rel normalised to nuclear actin in resting T cells are summarised
for one experiment in Figure 1B and for all three experiments in
Figure 5C and Table S1. Tubulin was not detected in the nuclear
extracts indicating that they were free of cytosolic contamination
(Figure 5A and B, panels 3). Nuclear p65 was detected at lower
levels overall in resting T cells than was c-Rel, and any increase
due to IkBe-deficiency was not consistently observed (Figure 5A
and B, panels 2 and Table S1); nuclear p50 was not detected. We
also observed increased basal IkBa expression in resting cells from
IkBe2/2 mice (Figure 5A, panel 4, Figure 5D, and Table S1), as
has been described [47].
c-Rel was detected in nuclei of resting IkBe2/2 T cells despite
increased expression of IkBa and normal levels of IkBb, indicating
that IkBe has a non-redundant role in the inhibition of c-Rel
nuclear translocation. We wondered whether T lymphocytes
would be primed for c-Rel-dependent upregulation of IL-2 in
IkBe2/2 mice. We found that, although PMA and ionomycin-
induced IL-2 expression showed an inverse correlation with IkBe
gene dose (Figure 5E), the effect was not statistically significant,
and there was no genotype-specific difference in IL-2 mRNA
expression by qRT-PCR, in T cell blasts stimulated with plate-
bound anti-CD3 (not shown). Further, there was no detectable
genotype-dependent difference in the amount of IL-2 secreted
following TCR-stimulation of naı ¨ve splenocytes or LNC, or T cell
blasts. By contrast, when we measured
3H-thymidine incorpora-
tion by naı ¨ve splenocytes and LNC in response to soluble anti-
CD3, we found that IkBe+/2 and 2/2 cells appeared more
sensitive to stimulation with concentrations of anti-CD3 of less
than 20 ng/ml than did WT cells, but the effect was statistically
significant only for IkBe2/2 cells (Figure 5F). Anti-CD28 alone
had no stimulatory effect and did not co-stimulate at concentra-
tions below 1 mg/ml.
Increased basal thymidine uptake in IkBe2/2 cells and
increased cellularity of IkBe2/2 lymph nodes
Increased basal thymidine incorporation by IkBe2/2 and
IkBe+/2 cells relative to WT cells was observed consistently for
splenocytes, LNC and T cell blasts, and was statistically significant
Figure 4. Association of IkBe with newly synthesised c-Rel and
p65/c-Rel complexes in TNF-treated cells. Control and TNF-treated
11A2 cells were restimulated with (A) (P+I)high, (B) P+Ilow, for the
indicated times. Nuclear and cytosolic extracts were prepared. (A) IkBs
a, b and e were immunoprecipitated from 100 mg cytosolic protein and
immunoblotted for associated c-Rel and p65. (B) p65-containing
complexes were immunoprecipitated from 100 mg cytosolic protein
and immunoblotted for associated IkB. Blots were probed and
reprobed for the indicated proteins and those shown are representative
of more than 3 experiments at both concentrations of P+I.
doi:10.1371/journal.pone.0024504.g004
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Splenocytes and LNCs from WT C57BL/6J (IkBe+/+, filled circles) mice, or mice hetero- (+/2, half-filled circles) or homozygous (2/2, open circles) for
IkBe deletion, were cultured with anti-CD3 for 48 hours, washed, then stimulated with IL-2 at day 2 and day 5. On day 7, cells were washed and
restimulated, or not, with plate-bound anti-CD3 for up to 4 hours. Extracts from resting and stimulated cells were analysed for (A) nuclear and
cytosolic NF-kB and IkB – a four-hour time-course is shown – (B) nuclear NF-kB – a two hour time-course representative of three experiments is
shown, with nuclear c-Rel and p65 normalised to actin and expressed relative to values for resting IkBe+/+ T cells as indicated. (C) Relative nuclear
expression of c-Rel (mean +/2 SD, n=3 experiments). (D) Cytosolic IkB for experiment shown in (B), with IkBa and -b normalised to actin and
Regulation of c-Rel by IkBe in Murine Lymphocytes
PLoS ONE | www.plosone.org 10 September 2011 | Volume 6 | Issue 9 | e24504for IkBe2/2 LNC (Figure 6A and 5F). However, this increase
was not due to c-Rel-dependent basal expression of IL-2 in
unstimulated cells, since it was not inhibited with blocking
antibodies to IL-2R (data not shown). We also noted that LN
were often larger in IkBe2/2 compared to WT mice (Figure 6B).
Furthermore, total numbers of LN cells, but not splenocytes, were
significantly higher for IkBe2/2 mice compared to heterozygote
or WT (Figure 6C). Phenotypic analysis revealed a trend towards
increased numbers of B220
high (mature B) cells in the LN of
IkBe2/2 mice (Figure 6D). We wondered whether increased
cellularity of lymph nodes, increased B cell numbers and enhanced
basal and TCR-stimulated thymidine uptake by LNC might be
explained by c-Rel dependent effects on lymphocyte survival in
IkBe2/2 mice. We therefore determined expression of the pro-
survival co-stimulatory molecule CD40 in WT and IkBe2/2 T
cell blasts by flow cytometry. Very few CD40+ T cells were




+ cells, which persisted in day 8 cultures of
IkBe2/2, but not WT, T cell blasts, were B220+ B cells (not
shown). That is, IkBe-/2 B cells were surviving longer than WT B
expressed relative to values for resting IkBe+/+ T cells as indicated. (E) T cells blasts were stimulated, or not, for 6 hours with PMA and ionomycin in
the presence of brefeldin A, labelled with anti-CD4-PECy7, fixed, permeabilised, labelled with anti-IL-2-FITC and analysed by flow cytometry. Shown
are% IL-2+CD4+ in the live cell gate (mean +/2 SD, n=3 experiments; one mouse per genotype per experiment). (F) LNC were cultured in triplicate
with soluble anti-CD3 at the concentrations indicated. At 48 hours, 1 mCi 3H-thymidine was added to each well and culture continued for 18 hours
prior to analysis of 3H-thymidine uptake. Mean +/2 SEM, n=5 experiments (one mouse per genotype per experiment); p values refer to IkBe2/2 vs
IkBe+/+, other P values were not significant.
doi:10.1371/journal.pone.0024504.g005
Figure 6. Increased basal thymidine uptake in splenocytes and LNC, increased LN cellularity and B cell numbers in IkBe2/2 mice. (A)
Basal thymidine uptake by splenocytes and LNCs in IkBe+/+, +/2 and 2/2 mice (median, n=10 experiments). (B) Enlarged axillary lymph node from
an IkBe2/2 mouse compared to those from IkBe+/+ and IkBe+/2. (C) Total lymph node cell numbers, one mouse per IkBe genotype per experiment
(mean +/2 SEM, n=10). (D) LNC were labelled with anti-CD4-PECy7, anti-CD8-PE, anti-B220-FITC and anti-CD11b-APC before flow cytometric analysis.
The percentage of each cell subset was multiplied by the total LNC number to give numbers for each cell subset (mean, n=6 experiments).
doi:10.1371/journal.pone.0024504.g006
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focussed our studies of IkBe/c-Rel-dependent regulation of
lymphocytes on B cells.
Increased basal nuclear c-Rel and enhanced BCR-
stimulated c-Rel translocation in naı ¨ve IkBe2/2 B cells
Splenic B lymphocytes were obtained from three each of age-
and sex-matched WT and IkBe2/2 mice. Cells were .93%
B220+ by flow cytometry after CD19+ positive selection (not
shown). First, we determined levels of c-Rel, p65 and IkB
isoforms in nuclear and cytoplasmic extracts of B cells cultured in
the presence or absence of stimulatory anti-IgM for up to one
hour. Basal levels of nuclear c-Rel relative to nuclear actin were
higher in naı ¨ve B cells from three IkBe2/2 mice compared to
those of WT (Figure 7, left side panel 1). Stimulation for 0.5 hour
with anti-IgM induced further nuclear translocation of c-Rel in
WT and IkBe2/2 B cells and this translocation was much
stronger in B cells from IkB2/2 mice (Figure 7, right side panel
1). After 1 hour’s stimulation, nuclear c-Rel in WT B cells
approached levels seen for IkBe2/2 B cells. Upon re-probe of
the same blot, basal nuclear p65 was not detected in WT or
IkBe2/2 B cells, and p65 was only faintly detectable in WT B
cell nuclear extracts after 1 hour’s BCR stimulation (Figure 7,
panels 2). p65 was strongly detected in one of the IkBe2/2 B
cell nuclear extracts at this time-point, but the sample appears to
be overloaded (see corresponding actin signal in panel 3).
Cytosolic expression of p65 was similar in WT and IkBe2/2
B cells throughout (Figure 7, panels 5). IkBe was detected in WT
but not IkBe2/2 B cell cytosols and was degraded following
BCR ligation (Figure 7, panels 6). Nuclear expression of c-Rel
was enhanced in the absence of IkBe even though IkBa
expression was higher in IkBe2/2 than in WT B cells
(Figure 7, panel 6), as had been the case for T cells. These data
strengthen the case for a non-redundant role of IkBe in the
regulation of c-Rel in lymphocytes.
Enhanced survival of naı ¨ve IkBe2/2 B cells is
characterised by increased basal expression of CD40 and
higher expression of BAFF-R ex vivo
To test whether enhanced nuclear translocation of c-Rel
affected lymphocyte survival, splenic B cells from 3 WT and 3
IkBe2/2mice were maintained for up to 72 hours either without
antigen receptor stimulation (Figure 8 A–C), or in the presence of
anti-IgM and IL-4 (Figure 8, D-F). TNF (20 ng/ml) was included
in some cultures to test whether it affected expression of IkBe,o r
behaviour of WT B cells ex vivo. Viability of cells was determined
by flow cytometry as the percentage of B220+ cells in the live cell
gate and in order to explore the mechanism of enhanced survival,
expression of c-Rel dependent pro-survival receptors CD40 and
BAFF-R on live B220+ cells was determined at the same time.
In the absence of BCR ligation, mean viability of B cells fell
rapidly between d0 and d1, and further from d1 to d2. Viability at
both d1 and d2 was significantly higher in IkBe2/2 B cells,
compared to WT cells (Figure 8B). Basal expression of CD40, and
Figure 7. Increased basal and BCR-inducible nuclear c-Rel in IkBe2/2 splenic B cells. Splenic B cells were isolated by CD19 positive
selection from three each of IkBe+/+ and IkBe2/2 mice. (A) Cells were rested for 2 hours then stimulated with anti-IgM F(ab’)2 fragment 10 mg/ml for
the times indicated at 10
7 B cells/ml per condition in a 12-well plate. There were insufficient cells from IkBe2/2 mouse 2, following selection, to carry
out stimulation of its B cells. Nuclear and cytoplasmic extracts from resting and stimulated cells were analysed for nuclear NF-kB and IkBb y
immunoblot. Nuclear and cytoplasmic c-Rel were normalised to actin and expressed relative to values for B cells of IkBe+/+ mouse 1 (mouse numbers
allocated randomly), as indicated.
doi:10.1371/journal.pone.0024504.g007
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cells. Splenic B cells were isolated by CD19 positive selection from three each of IkBe+/+ and IkBe2/2 mice, plated at 10
6/ml in 6-well plates without
stimulation for 48 hours, and analysed by flow cytometry for (A) viability, as% B220+ cells in the live cell gate (FSc/SSc), (B) median fluorescent
intensity (MFI APC) due to CD40 expression on CD40+ live B cells, (C) MFI FITC due to BAFF-R expression on BAFF-R+ live cells. Histograms are for one
set of randomly paired IkBe+/+ and IkB2/2 B cells, representative of three for each genotype. In a different experiment, splenic B cells were isolated
and plated as above, then stimulated with anti-IgM F(ab’)2 fragment 10 mg/ml and anti-IL-4 50 ng/ml (,250 u/ml) for 72 hours. Splenic B cells were
analysed for (D)% viability (FSc/SSc), (E) CD40 expression (MFI PE), and (F) BAFF-R (MFI APC) by flow cytometry.
doi:10.1371/journal.pone.0024504.g008
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higher in IkBe2/2 B cells (Figure 8B). Basal expression of BAFF-
R was similar for WT and IkBe2/2 B cells. However, BAFF-R
expression decreased with time in culture faster for WT than for
IkBe2/2 B cells, so that there were significant differences in
expression at d1 and d2 ex vivo (Figure 8C).
In the case of B cells receiving a pro-survival signal via anti-IgM
IL-4, there was a similar loss of viability in both WT and IkBe2/2
cells after one day in culture d1 of culture (Figure 8D). Viability
appeared to recover between d1 and d2 and, at d2, was significantly
greater for IkBe2/2 than for WT B cells. Basal expression of
CD40 and its expression at d1 of culture in anti-IgM and IL-4 was
significantlyhigherinIkBe2/2BcellsthanWTBcells(Figure8E).
CD40 expression was increased at d2 and d3 to a similar level in
both populations. Basal expression of BAFF-R was similar for WT
and IkBe2/2 B cells and BAFF-R was strongly induced in both
populations after 24 hours in culture, with significantly higher
expression on IkBe2/2 compared to WT cells B (Figure 8F). The
difference persisted and although less marked, it remained
statistically significant at d2 and d3 in culture (Figure 8C, D).
TNF had no effect on IkBe expression or survival ex vivo of WT B
cells, to 72 hours (not shown). These data suggest a non-redundant
role for IkBe in the regulation of c-Rel-dependent B lymphocyte
survival mechanisms.
Discussion
While studying mechanisms whereby pre-culture in TNF of
mouse T cell hybridoma 11A2 blocked subsequent IL-2 induction,
we observed that inhibition of IL-2 was associated with suppressed
nuclear translocation of c-Rel as well as increased expression and
attenuated inducible degradation of IkBe, but not IkBa or -b.
Nuclear expression of c-Fos, Fos B and NFAT2, and transcrip-
tional activation of not only NF-kB, but AP-1 and NFAT/AP-1
reporter promoters, were also attenuated in TNF-treated cells.
Deficits in AP-1 and NFAT expression and function are likely to
contribute to reduced inducibility of IL-2 in TNF-treated cells
both directly and indirectly, since induction of both IL-2 and c-Rel
require AP-1 and NFAT2 [26,30,50,51]. Transient reconstitution
of c-Rel in TNF-treated cells restored transcriptional activation of
a c-Rel/AP-1-dependent reporter to untreated control cell levels
but not to those of control cells also over-expressing c-Rel.
Therefore c-Rel alone did not fully reconstitute the inhibitory
effect of TNF at this promoter. It may be that effects of TNF on
AP-1 and NFAT expression and transcriptional activity accounted
for this deficit. TNF very likely had pleiotropic effects on 11A2
cells.
The consistent observations that c-Rel translocation was
strongly inhibited and that expression of IkBe, but not IkBa or
-b, was strongly upregulated in TNF-treated cells led us to
investigate the functional relationship of IkBe and c-Rel.
Extending our studies to primary lymphoid cells, we found that
IkBe appears to have a non-redundant role in regulation of c-Rel
subcellular localisation in B lymphocytes and T cell blasts, and a
negative regulatory role in B cell survival. We propose that IkBe
regulates the latter, at least in part, by inhibiting c-Rel-dependent
expression of anti-apoptotic molecules BAFF-R and CD40 in B
cells.
Reciprocity of IkBe levels and nuclear translocation of c-Rel
held for both TCR- and TNF-R-activated pathways in 11A2 cells
at all time-points of stimulation. Basal IkBe expression was
increased and remained higher at all time-points of stimulation
with PMA and ionomycin, or acute-on-chronic TNF, in TNF pre-
treated cells relative to controls. When we examined IkB/NF-kB
complexes by co-immunoprecipitation we observed that, whereas
c-Rel associated constitutively almost exclusively with IkBb, newly
synthesised c-Rel induced by PMA and ionomycin also associated
with IkBa and IkBe. This stimulation-dependent shift in IkB/c-
Rel complexes appears analogous to that (from IkBb to IkBa)
documented for cytokine-treated T cells [49]. The amount of
newly-synthesised c-Rel associating with IkBa reflected cytosolic
levels of c-Rel (Figure 4A, panel 1 and Figure S4 A(ii)). By contrast,
its association with IkBe reflected expression levels of IkBe in
control and TNF-treated cells (Figure 4A, panel 7 and Figure S4
A(ii)). In addition, more IkBe co-immunoprecipitated with p65/c-
Rel in TNF-treated than in control cell lysates of resting and PMA
and ionomycin-stimulated cells (Figure 4B, panel 5 and Figure
S4B). These were the only TNF-dependent differences in IkB/NF-
kB complexes, and seem likely to be a consequence simply of the
increased, stable expression of IkBe in TNF-treated cells.
Although its association with IkBe is most marked for newly-
synthesised c-Rel, IkBe over-expression also appeared to inhibit
nuclear translocation of constitutively-expressed c-Rel. Most c-Rel
was associated with IkBb in resting cells (Figure 4B, panel 4). Yet
following TNF-R ligation, despite equivalent degradation of IkBb
(and IkBa) in control and TNF pre-treated cells, very little pre-
existing c-Rel reached the nucleus in the latter (Figure 2B panel 2;
cf. Figure 2D panels 1–3). One explanation for this may be that
IkBe, being so strongly expressed in TNF pre-treated cells, binds
and inhibits c-Rel released in the wake of IkBb degradation.
We found IkBe expression to be upregulated in TNF-treated
cells, in all our experiments, at about the same time as another
study identified IkBe as a gene directly inducible by TNF [52]).
We also noted that IkBe appeared resistant to inducible
degradation in TNF-treated cells in many but not all experiments.
That there may be mechanisms of its regulation unique to IkBe is
suggested not only by its structural difference from the other IkBs
[8] but by IkBe-specific interactions with epsilon-regulatory
proteins such as PP6 regulatory unit 1(PP6R1) and ankyrin repeat
subunit (ARS)-A of PP6 which have recently been described.
Knock-down of either the PP6R1scaffolding unit or of ARS-A
(thought to mediate phosphatase substrate specificity) led to
enhanced TNF-induced degradation of IkBe [18,19,20].
IkBe is expressed in T and B lymphocytes [9,47] and it has been
shown that IkBe, like IkBb, prefers to bind c-Rel and p65 homo-
or heterodimers. This is in contrast to IkBa which preferentially
binds p65/p50 [8,10]. IkBe is expressed at high levels in splenic B
cells, in which it has been suggested to have a role in regulating a
subset of genes activated by p65 homodimers, since p65
homodimer-driven reporter gene expression increased as IkBe
was down-regulated during B cell maturation [9]. The same
authors had previously described constitutive nuclear c-Rel
expression in IgG+ but not IgM+ murine B cell lines, with 10-
fold lower expression of IkBe in the former.[53]. We found that
culture of WT murine T cell blasts (8 days) or splenic B cells (3
days) in TNF did not upregulate IkBe above its already-high
expression levels in the absence of TNF. It has further been
reported that c-Rel is constitutively nuclear in mature but not
naı ¨ve B cells [23]. We extended our investigation of specific
regulation of c-Rel by IkBe, and its functional outcomes, to studies
in lymphoid cells of WT and IkBe2/2 mice.
We argued that if IkBe had a unique role in regulation of c-Rel
nuclear translocation, as our in vitro experiments suggested, c-Rel
would accumulate in the nucleus of lymphocytes lacking IkBe,i n
the presence of normal levels of expression of IkBa and -b.W e
looked first in T cell blasts and found that c-Rel was present in the
nucleus of resting IkBe2/2 and IkBe+/2 T cells in the absence
of TCR signal (Figure 5A, B,C) and that this occurred despite
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induced nuclear translocation of c-Rel was seen for WT T cell
blasts, with less marked further nuclear accumulation of c-Rel in
IkBe2/2 T cells, suggesting that nuclear c-Rel was already closer
to its maximum in the latter. Nuclear c-Rel was also present at
higher levels in naı ¨ve splenic IkBe2/2 B cells, relative to WT,
and its early BCR-induced translocation was much more marked
in IkBe2/2 B cells than WT (Figure 7). Again, accumulation of
nuclear c-Rel occurred in IkBe2/2 B cells in the presence of
higher IkBa expression relative to WT cells. c-Fos and NFAT2
were not detected in nuclei of resting or stimulated B cells or T cell
blasts.
When we studied functional outcomes of enhanced c-Rel
nuclear translocation, we were surprised that IkBe2/2 T cells
(naı ¨ve or blast cells) did not make more IL-2 than WT cells when
stimulated via TCR ex vivo, and showed only a modest increase in
potential for IL-2 synthesis when stimulated with PMA and
ionomycin (Figure 5E). However, these findings were consistent
with a study which showed that inhibition of IL-2 expression in c-
Rel2/2 relative to that in wild-type T cells was not detectable
before 4 hours of TCR stimulation, that is, until the time when de-
novo synthesised c-Rel would accumulate in the nucleus [26]. The
authors also showed that basal and inducible transcription of IL-2
in T cells over-expressing c-Rel was between 2 and 3-fold greater
than in control cells but that this difference was lost at four hours’
stimulation when the gene was very strongly upregulated. By way
of comparison, basal and TCR-induced CD40 expression in c-
Rel2/2 T cells were inhibited at all time-points, relative to wild-
type, and c-Rel over-expression led to basal and inducible
transcription of CD40 that was between 15 and 40-fold greater
than that of controls throughout. We would argue that basal
nuclear expression of endogenous c-Rel in T lymphocytes is
actually unlikely to lead to enhanced IL-2 expression as a result of
the kinetics of regulation of this gene: TCR-induced activation of
IL-2 requires de novo synthesis of c-Rel, AP-1 and NFAT proteins
and their coordinate binding at pIL-2. Peak expression of these
factors coincides with maximum degradation of IkBe translocation
in wild type cells. Thus at the time (from about 2 hours post-
stimulation) when TCR-induced transcription of IL-2 would be
expected to begin in earnest, there would be effectively no
difference in IkBe between IkBe2/2 and WT cells. However,
under circumstances in which its expression is increased above
basal levels – in response to TNF, for instance, should this occur in
vivo – a role for IkBe in negative regulation of IL-2 gene induction
might become apparent.
Further observations led us to explore c-Rel responsive genes
besides IL-2 in IkBe2/2 lymphocytes. Firstly, naı ¨ve splenocytes
and LNCs of IkBe2/2 mice showed enhanced sensitivity to low
concentrations of anti-CD3, by thymidine incorporation assay,
and we consistently saw increased basal thymidine incorporation
in IkBe2/2 splenocyte, LNC and T cell blast cultures (Figures 5F
and 6A).
3H-thymidine uptake is usually taken as a correlate of IL-
2-dependent proliferation in T cell cultures, but it depends on the
number of live cells in culture at the time of its addition – typically
48 hours into culture – and so it also depends on cell survival ex
vivo [54]. Basal
3H-thymidine incorporation showed a reciprocal
relationship with IkBe gene dose which was not due to IL-2. This
might be explained either by increased basal proliferation or
enhanced survival ex vivo of IkBe2/2 cells. That is, if the viability
of IkBe2/2 cells exceeded that of WT cells, there would be more
of the former able to take up thymidine 48 hours into culture.
Secondly, LNs from IkBe2/2 mice, which often looked slightly
larger than those from WT mice, contained significantly increased
LNC numbers, with a trend to a higher proportion of B cells
(Figure 6, B–D). Thirdly, B cells from IkBe2/2 but not WT mice
survived for up to 8 days in conditions favouring T cell expansion
and survival.
From the data, we felt we were looking at a IkBe2/2 lymphoid
cell phenotype characterised chiefly by enhanced survival
mechanisms most clearly manifest in B cells. This interpretation
accords with previous adoptive transfer experiments which showed
a significant increase in splenic B cells of IkBe2/2 chimaeras as
compared to wild-type or IkBa mutant ones [55]. Having
established that naı ¨ve IkBe2/2 splenic B cells showed increased
basal nuclear expression and BCR-induced nuclear translocation
of c-Rel compared to WT, we found that survival of these cells was
significantly enhanced for up to 48 hours ex vivo in the presence or
absence of BCR ligation (Figure 8A and 8D). We demonstrated
significantly greater basal expression of CD40 in naı ¨ve IkBe2/2
splenic B cells relative to WT which persisted for 24 or 48 hours in
cells cultured in the presence or absence of anti-IgM and IL-4
respectively (Figure 8B and 8E). Finally, we observed a statistically
significant persistence of BAFF-R expression in unstimulated
IkBe2/2 B cells relative to WT for up to 48 hours culture ex vivo
(Figure 8C), and enhanced BCR-induced upregulation of BAFF-R
in IkBe2/2 compared to WT B cells, which was most marked at
24 hours, persisted for a further 48 hours (Figure 8D) and was also
statistically very significant. The higher basal and inducible
expression levels of these c-Rel-dependent pro-survival molecules
is a likely mechanism for the enhanced survival of IkBe2/2 B
cells ex vivo. CD40- and BAFF-R-dependent survival of B cells ex
vivo could in turn account for the increased basal thymidine uptake
ex vivo of IkBe2/2 splenocytes, LNCs and unstimulated T cell
cultures, relative to WT, both through B cell survival and the
ability of those B cells to deliver co-stimulation to T cells.
Enhanced B cell co-stimulation might also explain the greater
sensitivity of these cultures to low concentrations of anti-CD3.
Doerre and colleagues proposed an important role for IkBe in
differential regulation of genes responsive to p65 homodimers in
stimulated B cells [9]. A recent study describes IkBe as having a
specific role in regulating random variation of NF-kB activity from
cell to cell such as to permit cellular heterogeneity and
differentiation [56]. We propose that IkBe is a non-redundant
regulator of c-Rel in both T and B cells and that IkBe deficiency
or down-regulation leads to enhanced expression of c-Rel-
dependent genes that permit survival of, at least, B lymphocytes.
Given such effects on lymphoid cell survival, and the fact that c-
Rel is a proto-oncogene, we wondered whether IkBe2/2 mice
were predisposed to lymphatic tumours. However, no overt
tumour was detected in lymphoid tissues of male or female mice
aged up to 14 months. With hindsight, this is not surprising, since
there are no reports of transformation mediated solely by over-
expression of c-Rel in mice [23]. However, studies have implicated
gene variants in the IkBe/c-Rel pathway in tumorigenesis:
mutations in CD40, c-Rel and IkBe are associated with Hodgkin’s
Disease, a malignant transformation of germinal centre B cells. In
terms of other disease risks, rheumatoid arthritis-associated single
nucleotide polymorphisms have been described in PKCh, which
lies upstream of TCR-induced IkB degradation, in c-Rel, and in c-
Rel target genes CD40 and TNFAIP3 [57,58,59]; and IkBe itself
is upregulated at the mRNA level by TNF, whose over-expression
is a feature of rheumatoid arthritis and other inflammatory
diseases [52].
Our data suggest strongly that dysregulated expression of IkBe
will alter c-Rel-dependent survival and function of lymphocytes, its
under-expression or impaired function leading to enhanced
lymphocyte survival, and its over-expression or resistance to
degradation leading to impaired lymphocyte survival or function.
Regulation of c-Rel by IkBe in Murine Lymphocytes
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Supporting Information
Figure S1 PMA plus ionomycin-induced IL-2 mRNA is
stable in TNF-treated cells. Control and TNF-treated 11A2
cells were stimulated for four hours with P+Ilow prior to addition of
actinomycin D 10 mg/ml. Cells were harvested at the times
indicated and RNA extracted and analysed for IL-2 mRNA by
ribonuclease protection assay. (A) Phosphorimage of protected
RNA species; (B) IL-2 mRNA normalised to L32 mRNA and
expressed as% peak levels (at time of addition of actinomycin D)
for control and TNF-treated cells. Mean +/2 SD, 3 experiments.
(PDF)
Figure S2 Constitutive nuclear NFAT1 in 11A2 cells.
Dephosphorylation and nuclear translocation of NFAT1
in control and TNF-pre-treated cells. 11A2 cells were
cultured with or without TNF 2.5 ng/ml for 8 days before
restimulation with PMA 10 ng/ml and ionomycin 50 ng/ml
(P+I)low for the times indicated. Nuclear and cytoplasmic extracts
were prepared and equivalent amounts of proteins assayed for the
presence of NFAT1 by immunoblot. This filter was subsequently
re-probed for NFAT2 and loading controls (see Figure 1D).
Representative of three similar experiments.
(PDF)
Figure S3 Attenuation of DNA-binding for AP-1 proteins
and NFAT2 in TNF-treated cells. Control and TNF-treated
cells were stimulated for 4 hours with P+Ihigh. Nuclear extracts
were incubated with
32P-labelled (A)(B) AP-1 or (C) NFAT/AP-1
oligonucleotide, with or without supershifting antibodies for (A) fos
proteins, (B) jun proteins or (C) NFAT2. Protein-bound oligonu-
cleotide was visualised by phosphorimaging after gel electropho-
resis.
(PDF)
Figure S4 NF-kB and IkB in input cytosol and post-
immunoprecipitate supernatants. Control and TNF-treated
11A2 cells were stimulated with (P+I)low for the indicated times.
Nuclear and cytosolic extracts were prepared and either (A) IkBs
(a, b, e), or (B and C) p65 immunoprecipitated from 100 mg
cytosolic protein. (A) (i) IkB and (ii) NF-kB in input and post-IP
supernatants following immunoprecipitation with anti-IkB, 4 hour
time-point of PMA and ionomycin stimulation; (B) cytosolic NF-
kB and IkB in input and (C) input at t=0 h, and post-IP
supernatants following immunoprecipitation with anti-c-Rel or
anti-p65, at t=0 and 2 h PMA + ionomycin stimulation.
(PDF)
Table S1 Basal IkB and nuclear NF-kB expression in
IkBe sufficient, heterozygous and deficient murine T cell
blasts. Splenocytes and LNCs from IkBe+/+,I kBe+/2 or
IkBe2/2 mice, were cultured with anti-CD3 for 48 hours,
washed, then stimulated with IL-2 at day 2 and day 5. T cell blasts
were harvested on day 7. Nuclear and cytoplasmic extracts were
analysed for NF-kB and IkB by immunoblot. Following scanning
densitometry and quantitation, band volumes for each protein
were normalised against the corresponding value for actin. Mean
+/2 SD, n=3 experiments.
(DOC)
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